MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Asan Therapeutics

Small immunomodulatory molecules are an emerging class of cancer therapies. Due to quick clearance by the body (1-2 hrs), 3 - 4 injections/month are required. This increases the risk of infection, the cancer spreading, and lowers patient adherence. Our novel drug delivery platform technology provides delayed release (3-100 days) to simplify the treatment to just one monthly injection. We will start with skin, breast and pancreatic cancer patients, resulting in an initial market of $27+B.
We use a novel technology to simplify treatment of cancer patients to receive only a single injection instead of several painful injections.

Connect with Asan Therapeutics

Asan Therapeutics

2021

2021 Finalist BOS-96

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.